Evidence map›Paper›PMID 40161463›Full record

ArticleOphthalmology science

Epiretinal Membrane Is Associated with Diabetic Retinopathy Severity and Cumulative Anti-VEGF Injections.

Shinji Kakihara, Mohamed AbdelSalam, Kallista Zhuang, Amani A Fawzi

Registry-linked trialAbstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07241845 (Epiretinal Membrane in Patients With Diabetic Retinopathy.), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07241845 not yet recruitingnot on this map

Epiretinal Membrane in Patients With Diabetic Retinopathy.

Typeobservational_patient_registrySponsorAssiut UniversityRan2026 to 2028Enrolled225ConditionsEpiretinal MembraneArmsOCT
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shinji KakiharaDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Mohamed AbdelSalamDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Kallista ZhuangDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Amani A FawziDepartment of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To identify and assess the risk factors for epiretinal membrane (ERM) formation in patients with diabetes mellitus (DM). Design: A cross-sectional observational study. Participants: Diabetes mellitus subjects with varying severities of diabetic retinopathy (DR). Methods: Epiretinal membrane severity was graded using OCT macular volumetric scans. After comparing the features of eyes with and without ERM, a logistic regression model was employed to investigate risk factors for the presence of ERM formation, with explanatory variables that were statistically significant between 2 groups. Main Outcome Measures: The risk factors for ERM formation and their odds ratios. Results: The study analyzed 207 eyes of 207 patients without center-involving diabetic macular edema, including 44 with DM but no DR, 23 with mild DR, 42 with moderate DR, 28 with severe nonproliferative DR, and 70 with proliferative DR. Among these, 49 eyes had ERM. Eyes with ERM demonstrated significantly higher DR severity, more frequent history of cataract surgery, a greater number of anti-VEGF injections, less frequent hypertension, and higher geometric perfusion deficits in the deep capillary plexus, as calculated by OCT angiography, compared to eyes without ERM. After adjusting for explanatory variables, the logistic regression model identified DR severity and the number of injections as significant risk factors for ERM formation. The adjusted odds ratios were 2.388 (95% confidence interval [CI]: 1.694-3.566, Conclusions: In this cross-sectional study, DR severity as well as the number of anti-VEGF injections were identified as significant risk factors for ERM formation. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Anti-VEGF injectionsDiabetic retinopathyEpiretinal membraneOCT angiography

Identifiers

PMID40161463
PMCPMC11950736

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.